Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R von Roemeling

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Annals of the New York Academy of Sciences|January 1, 1991
The therapeutic index of cytotoxic chemotherapy depends upon circadian drug timingR Von Roemeling
Journal of the National Cancer Institute|March 7, 1990
Determination of the therapeutic index of floxuridine by its circadian infusion patternR von Roemeling, W J Hrushesky
Cancer Treatment Reports|November 1, 1986
Chemotherapy-induced vomiting: circadian drug timing as a source of predictable within-patient variabilityW J Hrushesky, R von Roemeling
Fortschritte Der Medizin|July 19, 1979
[Anemia. 1. Classification]H J König, R von Roemeling
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1989
Circadian patterning of continuous floxuridine infusion reduces toxicity and allows higher dose intensity in patients with widespread cancerR von Roemeling, W J Hrushesky
Die Medizinische Welt|December 22, 1979
[Multiple neoplasms after arsenic therapy]R von Roemeling, G Hartwich, H König
Fortschritte Der Medizin|September 28, 1978
[What are the dangers of splenectomy in Hodgkin's disease?]R von Roemeling, G Hartwich, B Neidhardt
Medizinische Klinik|September 29, 1978
[Treatment results of therapy resistant acute leukemias with 7 cystostatic agents (TRAMPCO-scheme)]G Hartwich, R von Roemeling, B Neidhardt
Fortschritte Der Medizin|November 8, 1979
[Anemias. 2. Differential diagnosis, normal values, diagnostic errors]R von Roemeling, H J König, G Hartwich
Fortschritte Der Medizin|January 17, 1980
[Anemias 3. Differential diagnosis]H J König, R von Roemeling, G Hartwich
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Annals of the New York Academy of Sciences|January 1, 1991
The therapeutic index of cytotoxic chemotherapy depends upon circadian drug timingR Von Roemeling
Journal of the National Cancer Institute|March 7, 1990
Determination of the therapeutic index of floxuridine by its circadian infusion patternR von Roemeling, W J Hrushesky
Cancer Treatment Reports|November 1, 1986
Chemotherapy-induced vomiting: circadian drug timing as a source of predictable within-patient variabilityW J Hrushesky, R von Roemeling
Fortschritte Der Medizin|July 19, 1979
[Anemia. 1. Classification]H J König, R von Roemeling
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1989
Circadian patterning of continuous floxuridine infusion reduces toxicity and allows higher dose intensity in patients with widespread cancerR von Roemeling, W J Hrushesky
Die Medizinische Welt|December 22, 1979
[Multiple neoplasms after arsenic therapy]R von Roemeling, G Hartwich, H König
Fortschritte Der Medizin|September 28, 1978
[What are the dangers of splenectomy in Hodgkin's disease?]R von Roemeling, G Hartwich, B Neidhardt
Medizinische Klinik|September 29, 1978
[Treatment results of therapy resistant acute leukemias with 7 cystostatic agents (TRAMPCO-scheme)]G Hartwich, R von Roemeling, B Neidhardt
Fortschritte Der Medizin|November 8, 1979
[Anemias. 2. Differential diagnosis, normal values, diagnostic errors]R von Roemeling, H J König, G Hartwich
Fortschritte Der Medizin|January 17, 1980
[Anemias 3. Differential diagnosis]H J König, R von Roemeling, G Hartwich
Pageof 4